Vigil Neuroscience, Inc. — Form D
Vigil Neuroscience, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-25. The offering totals $90.0M, of which $90.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-08-25
- Form: D
- Accession: 0001827087-21-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $90.0M
- Amount sold: $90.0M
- Investors: 19
- Date of first sale: 2021-08-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-411167
Issuer
- Name: Vigil Neuroscience, Inc.
- CIK: 0001827087
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1 BROADWAY, 7TH FLOOR, SUITE 07-300, CAMBRIDGE, MA, 02142
- Phone: 857-254-4445
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Cheryl Blanchard, Ph. D. | Director | Cambridge, MA |
| Clay Thorp | Director | Durham, NC |
| Bruce Booth | Director | Cambridge, MA |
| Stefan Vitorovic | Director | BOSTON, MA |
| Ivana Magovcevic-Liebisch | Director | CAMBRIDGE, MA |
| Ivana Magovcevic-Liebisch | Executive Officer | CAMBRIDGE, MA |
| Christopher Verni | Executive Officer | CAMBRIDGE, MA |
| Mary Thistle | Director | CAMBRIDGE, MA |
| Evan Thackaberry | Executive Officer | CAMBRIDGE, MA |
| Cheryl Blanchard | Director | CAMBRIDGE, MA |
| Suzanne Bruhn | Director | CAMBRIDGE, MA |
| Gerhard Koenig | Director | CAMBRIDGE, MA |
| Spyros Papapetropoulos | Executive Officer | CAMBRIDGE, MA |
| Jennifer Ziolkowski | Executive Officer | CAMBRIDGE, MA |
| Shaan Gandhi | Director | CAMBRIDGE, MA |
Other filings by this issuer (3)
More